Amneal Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
The acquisition of Kashiv BioSciences transforms Amneal into a vertically integrated biosimilars player, combining deep R&D and manufacturing with proven commercial scale. Management attributes the strategic pivot to an 'inflection point' in the biosimilars market, driven by accelerating physician adoption and regulatory advancements lowering development costs. First-quarter performance was driven by high market demand and increased supply for key women's health and ADHD products within the Affordable Medicines segment. The Specialty segment's 23% growth was fueled by strong market uptake of CREXONT and the rapid adoption of Brekiya for cluster headaches. Vertical integration is viewed as a critical competitive advantage to capture full economics and execute faster on a pipeline of 20-plus biosimilar programs. AvKARE's margin expansion of 690 basis points reflects a deliberate strategic shift toward high-margin government channels at the expense of low-margin distribution.
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pfizer's Monthly GLP-1 Push Tests Balance Between Obesity Growth And Dividends [Yahoo! Finance]Yahoo! Finance
- Pfizer Declares Second-Quarter 2026 DividendBusiness Wire
- Pfizer Could Surprise Again This Earnings Season (Preview) [Seeking Alpha]Seeking Alpha
- Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026 [Yahoo! Finance]Yahoo! Finance
- Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026Business Wire
PFE
Earnings
- 2/3/26 - Beat
PFE
Sec Filings
- 4/17/26 - Form 4
- 4/16/26 - Form 4
- 4/10/26 - Form 3
- PFE's page on the SEC website